<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="763204" id="root" date="1997-07-29" xml:lang="en">
<title>USA: SmithKline files supplemental NDA for Famvir.</title>
<headline>SmithKline files supplemental NDA for Famvir.</headline>
<dateline>PHILADELPHIA, Pa. 1997-07-29</dateline>
<text>
<p>SmithKline Beecham Plc said Tuesday that it has filed a supplemental new drug application with the U.S. Food and Drug Adminsitration for the use of Famvir to treat herpes in immunocompromised patients.</p>
<p>Famvir is currently approved for treatment of herpes simplex virus infections and acute herpes zoster, or shingles, in non-immunocompromised patients.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-29"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-29"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C13">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-29"/>
  </code>
  <code code="C22">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-29"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-29"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-07-29"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-07-29"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="PHILADELPHIA, Pa."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
